{"pub": "telegraph", "url": "https://telegraph.co.uk/politics/2019/10/13/eu-rules-could-make-cancer-deaths-likely-says-report", "downloaded_at": "2019-10-13 23:36:06.440414+00:00", "title": "EU rules could make cancer deaths more likely, says report", "language": "en", "text": "EU rules placing \u201cunreasonable burdens\u201d on drug licencing risk making cancer deaths more likely, two top scientists have warned.\n\nAngus Dalgleish, professor of oncology at the University of London and Professor Keith Lewis, director of science and technology consultancy Sciovis have criticised the EU\u2019s Clinical Trial Directive saying it has \"killed academic research\" by making trials so \"horrendously expensive\" that only the largest pharmaceutical companies can afford to get new products registered.\n\nIn their joint report, Let\u2019s Embrace World-Class Scientific Collaboration, the professors claim the directive is pushing up the cost of treatment for UK taxpayers with cancer drugs now costing an...", "description": "EU rules placing \u201cunreasonable burdens\u201d on drug licencing risk making cancer deaths more likely, two top scientists have warned.", "authors": ["Camilla Tominey", "Associate Editor", "Nick Timothy", "John Penrose", "Tom Welsh", "Daniel Hannan", "Jacob Rees-Mogg"], "top_image": "https://www.telegraph.co.uk/content/dam/politics/2019/09/21/TELEMMGLPICT000209976477-xlarge_trans_NvBQzQNjv4Bq3480UNUU8UfSxDSaY1n7MOcFT2AkRNXr2u2B8YtkTr4.jpeg?imwidth=1200", "published_at": "2019-10-13"}